News
From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head of gene therapy and vaccines, to return to the FDA after his abrupt ...
The global cancer gene therapy market size was US$ 1.5 billion in 2021. The global cancer gene therapy market is expected to grow to US$ 3.1 billion by 2030 by registering a compound annual growth ...
Hansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with Duchenne muscular dystrophy (DMD) with Sarepta and Roche’s Elevidys ...
16h
Zacks Investment Research on MSNSarepta to Report Q2 Earnings: What's in Store for the Stock?
We expect Sarepta Therapeutics SRPT to report second-quarter 2025 earnings on Aug. 6, after market close. The company’s ...
Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results